Marc Miskin of the School of Engineering and Applied Science commented on a new startup that is developing remote-control medical microrobots. “I would give them a lot of credit for figuring out a space where they can make an impact and justify how they’ll be competitive with traditional pharmaceutical approaches,” he said.

March 4, 2021 ・ From Los Angeles Times